38 results
6-K
EX-99.1
LEGN
Legend Biotech Corporation
20 Sep 24
Current report (foreign)
8:01am
team as discussed above, as well as to provide additional incentive awards to the Company’s current employees, consistent with the market
6-K
LEGN
Legend Biotech Corporation
8 Aug 24
Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
4:05pm
of the Company's Restricted Share Unit Incentive Plan (the "RSU Plan") and the Company's form of Restricted Share Unit Agreement, with vesting over
6-K
oe04otgzzlv
21 Dec 23
Current report (foreign)
4:15pm
F-3ASR
26zm5nom piwgzm
26 May 23
Automatic shelf registration (foreign)
9:01am
424B5
xjukauhfz9h 3ak
8 May 23
Prospectus supplement for primary offering
8:45am
6-K
EX-10.1
qjs8xr8h6 f3tahpfo
3 Oct 22
Legend Biotech Corporation 6-K
4:02pm
6-K
EX-10.1
q26vcyznzmw3xm m5
4 Aug 22
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
4:18pm
424B5
9ta n9vi47ve6gy
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
esncayb0igngffla9
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.4
e6k3eo
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
424B5
3oe6r
17 Dec 21
Prospectus supplement for primary offering
4:16pm
424B5
vhmsmids dtuvwqy66n
14 Dec 21
Prospectus supplement for primary offering
4:40pm
6-K
EX-99.4
d3wq58he
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
424B3
5scqgcrybfewi0f4ghe
14 Jul 21
Prospectus supplement
4:06pm